Zacks Research Has Positive View of HealthEquity Q2 Earnings

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Equities research analysts at Zacks Research lifted their Q2 2026 earnings per share (EPS) estimates for HealthEquity in a research note issued on Tuesday, June 24th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.70 per share for the quarter, up from their prior estimate of $0.68. The consensus estimate for HealthEquity's current full-year earnings is $2.32 per share. Zacks Research also issued estimates for HealthEquity's Q3 2026 earnings at $0.73 EPS, Q4 2026 earnings at $0.76 EPS, FY2026 earnings at $3.05 EPS, Q1 2027 earnings at $0.81 EPS, Q4 2027 earnings at $0.96 EPS, FY2027 earnings at $3.59 EPS, Q1 2028 earnings at $0.99 EPS and FY2028 earnings at $4.18 EPS.

Other research analysts also recently issued reports about the company. Bank of America boosted their price target on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Royal Bank Of Canada upped their target price on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Barrington Research raised their price target on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. JMP Securities upped their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research note on Wednesday, June 4th. Finally, Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $118.09.

HealthEquity Trading Up 0.0%

Shares of HealthEquity stock traded up $0.03 during mid-day trading on Friday, hitting $104.91. 610,823 shares of the stock were exchanged, compared to its average volume of 855,767. The company has a 50-day simple moving average of $98.01 and a 200 day simple moving average of $98.02. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $9.07 billion, a price-to-earnings ratio of 76.58, a price-to-earnings-growth ratio of 1.61 and a beta of 0.49. HealthEquity has a twelve month low of $65.01 and a twelve month high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. The business had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter in the prior year, the business earned $0.80 earnings per share.

Insider Buying and Selling

In other news, EVP Elimelech Rosner sold 58,000 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the transaction, the executive vice president now directly owns 75,689 shares in the company, valued at approximately $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 304,581 shares of company stock valued at $33,664,018. Company insiders own 1.50% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HQY. Voya Investment Management LLC boosted its stake in HealthEquity by 96.5% during the 1st quarter. Voya Investment Management LLC now owns 153,413 shares of the company's stock valued at $13,557,000 after acquiring an additional 75,341 shares during the last quarter. Inspire Investing LLC grew its holdings in shares of HealthEquity by 8.6% during the first quarter. Inspire Investing LLC now owns 7,529 shares of the company's stock valued at $665,000 after purchasing an additional 597 shares during the last quarter. Hodges Capital Management Inc. acquired a new position in HealthEquity during the 1st quarter valued at approximately $1,988,000. Strs Ohio bought a new stake in HealthEquity in the first quarter valued at $999,000. Finally, Mattson Financial Services LLC boosted its stake in HealthEquity by 15.5% during the 1st quarter. Mattson Financial Services LLC now owns 1,988 shares of the company's stock valued at $176,000 after purchasing an additional 267 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.